SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors

NCT05354843 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ET0038

Sponsor

Etern BioPharma (Shanghai) Co., Ltd